|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-4-25
|
|
pubmed:abstractText |
Cyclooxygenase-2 (COX-2) seems to be involved in critical steps of cancer onset and progression. Abnormalities of epidermal growth factor receptor (EGFR) and Her-2/neu have been actively investigated in ovarian cancer and associated with unfavorable clinical outcome. The involvement of COX-2 in ErbB family pathways has been proposed. We investigated by immunohistochemistry the expression of COX-2, EGFR, and Her-2/neu in a series of advanced primary ovarian cancers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2002 Elsevier Science (USA).
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
305-10
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:11972392-Cyclooxygenase 2,
pubmed-meshheading:11972392-Female,
pubmed-meshheading:11972392-Humans,
pubmed-meshheading:11972392-Immunohistochemistry,
pubmed-meshheading:11972392-Isoenzymes,
pubmed-meshheading:11972392-Membrane Proteins,
pubmed-meshheading:11972392-Neoplasm Staging,
pubmed-meshheading:11972392-Ovarian Neoplasms,
pubmed-meshheading:11972392-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:11972392-Receptor, Epidermal Growth Factor,
pubmed-meshheading:11972392-Receptor, erbB-2
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Largo A. Gemelli 8, 00168 Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
